UNC chemist to partner on nanoparticle vaccine for prostate cancer
UNC chemist Joseph DeSimone will partner with scientists at two universities and a local biotechnology company to develop a nanoparticle vaccine for prostate cancer. The Prostate Cancer Foundation (PCF) awarded the UNC-Beth Israel Deaconess Medical Center/Harvard-Johns Hopkins-Liquidia Technologies consortium a Challenge Award of $1 million, one of 10 such awards funded by the organization. DeSimone […]
UNC chemist to partner on nanoparticle vaccine for prostate cancer Read More »